45.11
price down icon1.16%   -0.53
pre-market  시장 영업 전:  44.72   -0.39   -0.86%
loading

Veracyte Inc (VCYT) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-09-30 2024-03-31
기간 3개월 3개월 3개월 3개월
Revenues
13.71%
130.16
114.47 115.86 96.84
Cost Of Revenue
15.53%
40.40
34.97 36.85 -
Gross Profit
12.91%
89.77
79.51 79.01 -
Operating Expenses
24.06%
95.04
76.60 66.99 101.50
Benefits Costs and Expenses
20.43%
128.91
107.05 99.01 98.75
Costs And Expenses
24.06%
95.04
76.60 66.99 101.50
Operating Income/Loss
281.40%
-5.268
2.904 12.02 -4.656
Income/Loss From Continuing Operations Before Tax
83.17%
1.25
7.428 16.85 -1.908
Income Tax Expense/Benefit
485.30%
2.23
0.381 1.693 -0.044
Income/Loss From Continuing Operations After Tax
113.91%
-0.98
7.047 15.15 -1.864
Net Income/Loss
113.91%
-0.98
7.047 15.15 -1.864
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
0.47%
78.39
78.03 77.01 74.76
Diluted Average Shares
2.08%
78.39
80.06 78.46 74.76
Basic Earnings Per Share
111.11%
-0.01
0.09 0.20 -0.02
Diluted Earnings Per Share
111.11%
-0.01
0.09 0.19 -0.02
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
diagnostics_research LH
$253.73
price down icon 2.56%
$150.14
price up icon 2.06%
diagnostics_research WAT
$399.41
price down icon 0.28%
diagnostics_research MTD
$1,470.87
price down icon 0.96%
$254.40
price up icon 2.28%
diagnostics_research IQV
$244.29
price up icon 1.56%
자본화:     |  볼륨(24시간):